INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. & Encourages...
October 31 2016 - 5:53PM
Business Wire
Goldberg Law PC, a national shareholder rights litigation firm,
announces a class action lawsuit has been filed against Spectrum
Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (Nasdaq: SPPI).
Investors who purchased or otherwise acquired shares between
February 28, 2013 and September 16, 2016 inclusive (the “Class
Period”) are encouraged to contact the firm in advance of the
November 21, 2016 lead plaintiff motion
deadline.
If you are a shareholder who suffered a loss during the Class
Period, click here to participate. In addition, we encourage
you to contact Michael Goldberg or Brian Schall, of Goldberg Law
PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
The Complaint alleges that during the Class Period, Spectrum
made false and/or misleading statements and/or failed to disclose
that: the U.S. Food and Drug Administration (the “FDA”) previously
questioned whether the data from the 611 and 612 Studies (the names
of the Phase 3 studies for apaziquone) were clinically significant;
that the FDA instructed the Company in December 2012 not to submit
the New Drug Application based on data from the 611 and 612
Studies; and that as a result of the above, the Company’s public
statements regarding the its business, operations and prospects
were materially false and misleading at all relevant times. When
this news was announced, shares of Spectrum fell in value, causing
the investors harm.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161031006292/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comwww.Goldberglawpc.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From May 2023 to May 2024